Search

everythinglearnresearchcommunity

for

Search:↓

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Antibiotics can reduce acne but may lead to resistant bacteria, and understanding the skin's bacteria is important for treatment.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Activating TRPV3 stops human hair growth.

Minoxidil and finasteride effectively treat hair loss.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

Both mouse and rat models are effective for testing alopecia areata treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

CYP2B12 enzyme in skin cells converts arachidonic acid into specific bioactive lipids.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.